Colorectal Neoplasms
662
75
97
308
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
81 trials with published results (12%)
Research Maturity
308 completed trials (47% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.5%
63 terminated out of 662 trials
83.0%
-3.6% vs benchmark
10%
66 trials in Phase 3/4
26%
81 of 308 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 308 completed trials
Clinical Trials (662)
Preventing Early-Onset Colorectal Cancer in the VA
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
HTL0039732 in Participants With Advanced Solid Tumours
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
PRE-ISPY Phase I/II Oncology Platform Program
An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal Cancer Chemotherapy
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
TQB2922 Injection Given Under the Skin With Chemotherapy as Initial Treatment for Colorectal Cancer That Has Spread
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
First in Human Study of AZD9592 in Solid Tumors
Right Colon Enema to Improve Bowel Preparation Quality During Colonoscopy
A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
Liquid Biopsy Biomarkers for Endoscopic Surveillance in Lynch Syndrome
Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors